Evidence map›Paper›PMID 14681543›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2003

Proteins of multiple classes may participate in nongenomic steroid actions.

Cheryl S Watson, Bahiru Gametchu

Open access · greenAbstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways.The Journal of steroid biochemistry and molecular biology · 2011
    Review
  12. Article
  13. Article
  14. Article
  15. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2008
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Cheryl S WatsonDepartment of Human Biological Chemistry and Genetics, University of Texas, Medical Branch, Galveston, Texas 77555, USA. cswatson@utmb.edu
Bahiru Gametchu
Medical College of Wisconsin · USThe University of Texas Medical Branch at Galveston · US

Funding

Environmental Estrogens Acting via a Membrane ReceptorR01ES010987 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WATSON, CHERYL S · 2002 to 2004
$660k
NIEHS NIH HHS R01 ES010987
6 · The paper itself

Abstract

Responses to steroids initiated from non-nuclear receptors impinge on a wide variety of cellular responses and utilize nearly all known signal transduction webs. While the mechanisms by which steroid receptors localize in the membrane are still unclear, it is apparent that this alternative localization allows steroid receptors to participate in a wide range of complex functions influencing cell proliferation, death, and differentiation. The central debate still remains the identity of the protein class or classes that mediate membrane-initiated (nongenomic) responses. The data thus far have supported several possibilities, including: nuclear steroid receptor-like forms in non-nuclear locations; other known (nonsteroid) membrane receptors or channels with additional steroid-binding sites; enzymes; transporters; receptors for serum steroid-binding proteins; unique and previously undescribed proteins; or chimeras of typical steroid receptor domains with other unique or known protein domains. Categorizing membrane steroid receptor proteins based exclusively on the actions of antagonists and agonists, without considering cell context and protein partnering issues, may mislead us into predicting more receptor subtypes than really exist. However, the plethora of signaling and functional outcomes may indicate the participation of more than one kind of steroid-binding protein. Resolving such unanswered questions will require future investigative focus on this alternative arm of steroid action, which is likely to yield as many therapeutic opportunities as have nuclear steroid mechanisms.

Indexed as

AnimalsFemaleHumansMaleMembrane ProteinsModels, BiologicalReceptors, Cell SurfaceReceptors, SteroidSignal TransductionSteroidsMembrane ProteinsReceptors, Cell SurfaceReceptors, SteroidSteroids

Identifiers

PMID14681543
PMCPMC1224708
OpenAlexW1820420430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.